No one knows what’s right around the corner given the geopolitical turmoil. Still, stocks jumped slightly through morning trading on Tuesday after the Nasdaq and the S&P 500 charged higher to start ...

Bayer has joined its peers among European drugmakers with a hike in pharma forecasts for the year, as it recorded a rise in group sales, but lower profits for the second quarter. Total revenues came ...

None ...